Exosome RNA Exosome RNA Research & Industry News
Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad...
Read More »Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio
ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome
ExoCoBio, one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims that stem cell-derived exosome is proved as effective ingredient for...
Read More »First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted
Aptorum Group Limited, a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the patent regarding the Rapid Pathogen Infectious Disease Liquid Biopsy Diagnostics...
Read More »Evox Therapeutics Expands Its Exosome Patent Portfolio
Newly issued patent covers proprietary approach for loading nucleic acids into exosomes Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has...
Read More »EDGC applies for liquid biopsy cancer detection technology patent
A Korean genetic sequencing firm has taken a step towards the commercialization of its liquid biopsy technology, which aims at detecting early stage cancer with a simple blood test and suggesting optimized treatment. Eone Diagnomics Genome Center (EDGC) announced that ...
Read More »Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1 Diabetes Immunotherapy Using Exosomes from MyeloCelz™ Platform
Creative Medical Technology Holdings announced today filing a new patent application covering nanoparticles called “exosomes” secreted by cells of its...
Read More »Vesigen Therapeutics announces issuance of U.S. patent for broad applications of its novel extracellular vesicle delivery technology
Vesigen Therapeutics, a biotechnology company pioneering a novel extracellular vesicle delivery technology to develop transformative therapeutics, today...
Read More »WO2021033990 – Composition Comprising Exosomes Derived from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Precursor for Prevention or Treatment of Non-Alcoholic Steatohepatitis
The present invention relates to a pharmaceutical composition for prevention or treatment of non-alcoholic steatohepatitis, the composition comprising, as an active ingredient, exosomes isolated from induced...
Read More »Evox Therapeutics expands its existing exosome patent portfolio
Evox Therapeutics, a leading exosome therapeutics company, is pleased to announce that the Company has been granted another key patent by the European Patent Office (EPO). This new grant...
Read More »Ymir Genomics & (OHSU) announce a licensing agreement and patent application covering miRNA biomarkers discovered utilizing Ymir’s extracellular vesicle isolation technology
Ymir Genomics LLC (Ymir) and the Oregon Health & Science University (OHSU) Knight Cancer Institute today announced a licensing agreement and filed patent application that seeks to protect and promote newly-discovered high value urinary biomarkers for detecting cirrhosis and/or hepatocellular ...
Read More »